Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
丹黄癃欣胶囊治疗慢性前列腺炎(湿热下注证)有效性、安全性的随机、双盲、剂量平行对照、多中心临床试验
[Translation] A randomized, double-blind, dose-parallel controlled, multicenter clinical trial of Danhuanglongxin capsules in the treatment of chronic prostatitis (damp-heat injection syndrome)
初步评价丹黄癃欣胶囊治疗慢性前列腺炎(湿热下注证)的有效性和安全性,同时对本品剂量及疗程进行探索,为Ⅲ期临床试验提供依据。
[Translation] To preliminarily evaluate the efficacy and safety of Danhuang Longxin Capsule in the treatment of chronic prostatitis (damp-heat injection syndrome), and to explore the dosage and course of treatment of this product to provide the basis for phase III clinical trials.
100 Clinical Results associated with Beijing Liushenghe Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Beijing Liushenghe Pharmaceutical Technology Co., Ltd.
100 Deals associated with Beijing Liushenghe Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Beijing Liushenghe Pharmaceutical Technology Co., Ltd.